Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis

Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use

(2017) Maren Carbon et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Comparison of Ziprasidone and Risperidone in the Long-Term Treatment of Schizophrenia: A 44-Week, Double-Blind, Continuation Study

(2017) Donald E Addington et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Dose Equivalents for Antipsychotic Drugs: The DDD Method: Table 1.

(2016) Stefan Leucht et al.   SCHIZOPHRENIA BULLETIN

Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol

(2015) A. Parabiaghi et al.   ACTA PSYCHIATRICA SCANDINAVICA

Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management

(2015) P. Manu et al.   ACTA PSYCHIATRICA SCANDINAVICA

Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies

(2015) Pál Czobor et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia

(2015) Dieter Naber et al.   SCHIZOPHRENIA RESEARCH

Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia

(2014) Joseph P. McEvoy et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Incidence of Tardive Dyskinesia in Older Adult Patients Treated With Olanzapine or Conventional Antipsychotics

(2014) Bruce J. Kinon et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Treatment of neurolept-induced tardive dyskinesia

(2013) Stacey Jankelowitz   Neuropsychiatric Disease and Treatment

Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs

(2012) Michael J. Peluso et al.   BRITISH JOURNAL OF PSYCHIATRY

Long-term safety and tolerability of lurasidone in schizophrenia

(2012) Leslie Citrome et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial

(2011) Ragy R. Girgis et al.   BRITISH JOURNAL OF PSYCHIATRY

Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: A pragmatic, randomized trial

(2011) E. Johnsen et al.   EUROPEAN PSYCHIATRY

Asenapine Versus Olanzapine in People With Persistent Negative Symptoms of Schizophrenia

(2011) Robert W. Buchanan et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head–head comparisons

(2011) Peter M Haddad et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A Pilot, 15-month, randomised effectiveness trial of Risperidone long-acting injection (RLAI) versus oral atypical antipsychotic agents (AAP) in persons with bipolar disorder

(2010) K. N. Roy Chengappa et al.   ACTA NEUROPSYCHIATRICA

Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study

(2010) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications

(2010) Scott W. Woods et al.   JOURNAL OF CLINICAL PSYCHIATRY

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

(2010) Wolfgang Gaebel et al.   NEUROPSYCHOPHARMACOLOGY

Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder

(2010) J. Schoemaker et al.   PHARMACOPSYCHIATRY

A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia

(2010) Herbert Y. Meltzer et al.   PSYCHIATRY RESEARCH

How to read and understand and use systematic reviews and meta-analyses

(2009) S. Leucht et al.   ACTA PSYCHIATRICA SCANDINAVICA

Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis

(2009) Manuel J. Cuesta et al.   BRITISH JOURNAL OF PSYCHIATRY

Olanzapine compared to quetiapine in adolescents with a first psychotic episode

(2009) Celso Arango et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol

(2009) Steven G. Potkin et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

(2009) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extrapyramidal side-effects of antipsychotics in a randomised trial

(2008) Del D. Miller et al.   BRITISH JOURNAL OF PSYCHIATRY

Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia

(2008) Christopher Kenney et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial

(2008) Peter Tyrer et al.   LANCET